Convenient entry to N-pyridinylureas with pharmaceutically privileged oxadiazole substituents via the acid-catalyzed C H activation of N-oxides

[1]  V. Sharoyko,et al.  1,2,4-Oxadiazole/2-Imidazoline Hybrids: Multi-target-directed Compounds for the Treatment of Infectious Diseases and Cancer , 2019, International journal of molecular sciences.

[2]  C. Supuran,et al.  Continued exploration of 1,2,4-oxadiazole periphery for carbonic anhydrase-targeting primary arene sulfonamides: Discovery of subnanomolar inhibitors of membrane-bound hCA IX isoform that selectively kill cancer cells in hypoxic environment. , 2019, European journal of medicinal chemistry.

[3]  Wenqiang Jia,et al.  Identification and Structure-Activity Relationship (SAR) of potent and selective oxadiazole-based agonists of sphingosine-1-phosphate receptor (S1P1). , 2019, Bioorganic chemistry.

[4]  A. Osipyan,et al.  Novel monoamine oxidase inhibitors based on the privileged 2-imidazoline molecular framework. , 2019, Bioorganic & medicinal chemistry letters.

[5]  Shi Hua Ang,et al.  Discovery of dual GyrB/ParE inhibitors active against Gram-negative bacteria. , 2018, European journal of medicinal chemistry.

[6]  M. Tarasenko,et al.  One-Pot Synthesis of 3,5-Disubstituted 1,2,4-Oxadiazoles Using Catalytic System NaOH‒DMSO , 2018, Russian Journal of Organic Chemistry.

[7]  Zhe-Sheng Chen,et al.  Discovery of 5-Cyano-6-phenylpyrimidin Derivatives Containing an Acylurea Moiety as Orally Bioavailable Reversal Agents against P-Glycoprotein-Mediated Mutidrug Resistance. , 2018, Journal of medicinal chemistry.

[8]  S. Baykov,et al.  Facile room-temperature assembly of the 1,2,4-oxadiazole core from readily available amidoximes and carboxylic acids , 2018, Tetrahedron Letters.

[9]  I. V. Tarasova,et al.  Glucokinase Activators Based on N-Aryl-N′-Pyridin-2-Ylurea Derivatives , 2018, Pharmaceutical Chemistry Journal.

[10]  J. A. Arjona Ferreira,et al.  Phase 1, Randomized, Double‐Blind, Placebo‐Controlled Studies on the Safety, Tolerability, and Pharmacokinetics of Naldemedine in Healthy Volunteers , 2018, Clinical pharmacology in drug development.

[11]  Fang-Wei Liu,et al.  Cobalt Complex with Redox-Active Imino Bipyridyl Ligand for Electrocatalytic Reduction of Carbon Dioxide to Formate. , 2018, ChemSusChem.

[12]  R. Kant,et al.  Synthesis, molecular modelling studies and ADME prediction of benzothiazole clubbed oxadiazole-Mannich bases, and evaluation of their anti-diabetic activity through in vivo model. , 2018, Bioorganic chemistry.

[13]  Jing-wei Liang,et al.  Design, synthesis and anticancer activities evaluation of novel 5H-dibenzo[b,e]azepine-6,11-dione derivatives containing 1,3,4-oxadiazole units. , 2018, Bioorganic & medicinal chemistry letters.

[14]  A. Wadood,et al.  Oxindole based oxadiazole hybrid analogs: Novel α-glucosidase inhibitors. , 2018, Bioorganic chemistry.

[15]  P. Furet,et al.  2-Formylpyridyl Ureas as Highly Selective Reversible-Covalent Inhibitors of Fibroblast Growth Factor Receptor 4. , 2018, ACS medicinal chemistry letters.

[16]  C. Supuran,et al.  Heterocyclic periphery in the design of carbonic anhydrase inhibitors: 1,2,4-Oxadiazol-5-yl benzenesulfonamides as potent and selective inhibitors of cytosolic hCA II and membrane-bound hCA IX isoforms. , 2018, Bioorganic chemistry.

[17]  Jiyoun Lee,et al.  Synthesis and evaluation of 2-(3-arylureido)pyridines and 2-(3-arylureido)pyrazines as potential modulators of Aβ-induced mitochondrial dysfunction in Alzheimer's disease. , 2018, European journal of medicinal chemistry.

[18]  S. Banskota,et al.  Protective effects of 6-ureido/thioureido-2,4,5-trimethylpyridin-3-ols against 4-hydroxynonenal-induced cell death in adult retinal pigment epithelial-19 cells. , 2018, Bioorganic & medicinal chemistry letters.

[19]  David M. Shackleford,et al.  Progress in antischistosomal N,N'-diaryl urea SAR. , 2017, Bioorganic & medicinal chemistry letters.

[20]  A. V. Smirnov,et al.  Room-temperature synthesis of pharmaceutically important carboxylic acids bearing the 1,2,4-oxadiazole moiety , 2017 .

[21]  Jiyoun Lee,et al.  Discovery of 1-(3-(benzyloxy)pyridin-2-yl)-3-(2-(piperazin-1-yl)ethyl)urea: A new modulator for amyloid beta-induced mitochondrial dysfunction. , 2017, European journal of medicinal chemistry.

[22]  Chen-Chen Ma,et al.  Design and Synthesis of Coumarin Derivatives as Novel PI3K Inhibitors. , 2017, Anti-cancer agents in medicinal chemistry.

[23]  A. V. Smirnov,et al.  The first one-pot ambient-temperature synthesis of 1,2,4-oxadiazoles from amidoximes and carboxylic acid esters , 2017 .

[24]  V. Boyarskiy,et al.  Solvent- and halide-free synthesis of pyridine-2-yl substituted ureas through facile C–H functionalization of pyridine N-oxides , 2016 .

[25]  Sandy J. Wilson,et al.  The SAR of brain penetration for a series of heteroaryl urea FAAH inhibitors. , 2016, Bioorganic & medicinal chemistry letters.

[26]  Chen Chen,et al.  Design, synthesis, biological evaluation and docking studies of novel 2-substituted-4-morpholino-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine derivatives as dual PI3Kα/mTOR inhibitors. , 2016, European journal of medicinal chemistry.

[27]  A. V. Smirnov,et al.  A convenient and mild method for 1,2,4-oxadiazole preparation: cyclodehydration of O-acylamidoximes in the superbase system MOH/DMSO , 2016 .

[28]  P. Coward,et al.  5-Alkyl-2-urea-Substituted Pyridines: Identification of Efficacious Glucokinase Activators with Improved Properties , 2016, ACS medicinal chemistry letters.

[29]  A. Cheng,et al.  Novel Series of Potent Glucokinase Activators Leading to the Discovery of AM-2394. , 2016, ACS medicinal chemistry letters.

[30]  Sandy J. Wilson,et al.  Preclinical Characterization of the FAAH Inhibitor JNJ-42165279. , 2015, ACS medicinal chemistry letters.

[31]  L. Meijer,et al.  Advances in tetrahydropyrido[1,2-a]isoindolone (valmerins) series: Potent glycogen synthase kinase 3 and cyclin dependent kinase 5 inhibitors. , 2015, European journal of medicinal chemistry.

[32]  V. Boyarskiy,et al.  Facile Gold-Catalyzed Heterocyclization of Terminal Alkynes and Cyanamides Leading to Substituted 2-Amino-1,3-Oxazoles. , 2015, Organic letters.

[33]  A. Hamilton,et al.  β-Strand mimetic foldamers rigidified through dipolar repulsion. , 2015, Angewandte Chemie.

[34]  A. P. Piccionello,et al.  Recent Advances in the Chemistry of 1,2,4-OxadiazolesaaDedicated to Professor Nicolò Vivona on the occasion of his 75th birthday. , 2015 .

[35]  P. Coward,et al.  C5-Alkyl-2-methylurea-Substituted Pyridines as a New Class of Glucokinase Activators. , 2014, ACS medicinal chemistry letters.

[36]  C. Fishwick,et al.  Pyridine-3-carboxamide-6-yl-ureas as novel inhibitors of bacterial DNA gyrase: structure based design, synthesis, SAR and antimicrobial activity. , 2014, European journal of medicinal chemistry.

[37]  M. McVean,et al.  Discovery of 2-pyridylureas as glucokinase activators. , 2014, Journal of medicinal chemistry.

[38]  Y. Yamaguchi,et al.  Structure-activity relationship studies and discovery of a potent transient receptor potential vanilloid (TRPV1) antagonist 4-[3-chloro-5-[(1S)-1,2-dihydroxyethyl]-2-pyridyl]-N-[5-(trifluoromethyl)-2-pyridyl]-3,6-dihydro-2H-pyridine-1-carboxamide (V116517) as a clinical candidate for pain management , 2014, Journal of medicinal chemistry.

[39]  H. Takagi,et al.  A meta-analysis of randomized controlled trials of azilsartan therapy for blood pressure reduction , 2014, Hypertension Research.

[40]  M. Karbarz,et al.  Heteroarylureas with spirocyclic diamine cores as inhibitors of fatty acid amide hydrolase. , 2014, Bioorganic & medicinal chemistry letters.

[41]  C. Supuran,et al.  Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: solution and X-ray crystallographic studies. , 2014, Bioorganic & medicinal chemistry.

[42]  Liming Zhang,et al.  Synthesis, characterization and striking photoluminescence variation of a series of copper(I) complexes containing oxadiazole ligand , 2013 .

[43]  L. Meijer,et al.  Novel tetrahydropyrido[1,2-a]isoindolone derivatives (valmerins): potent cyclin-dependent kinase/glycogen synthase kinase 3 inhibitors with antiproliferative activities and antitumor effects in human tumor xenografts. , 2012, Journal of medicinal chemistry.

[44]  Sandy J. Wilson,et al.  Aryl Piperazinyl Ureas as Inhibitors of Fatty Acid Amide Hydrolase (FAAH) in Rat, Dog, and Primate. , 2012, ACS medicinal chemistry letters.

[45]  Stephen D. Pickett,et al.  The developability of heteroaromatic and heteroaliphatic rings – do some have a better pedigree as potential drug molecules than others? , 2012 .

[46]  Channa K. Hattotuwagama,et al.  Lead-oriented synthesis: a new opportunity for synthetic chemistry. , 2012, Angewandte Chemie.

[47]  Jonas Boström,et al.  Oxadiazoles in medicinal chemistry. , 2012, Journal of medicinal chemistry.

[48]  E. R. Kofanov,et al.  Formation and cyclization of N′-(benzoyloxy)benzenecarboximidamides , 2011 .

[49]  A. Pace,et al.  The new era of 1,2,4-oxadiazoles. , 2009, Organic & biomolecular chemistry.

[50]  Meenal Patel,et al.  PTC124 targets genetic disorders caused by nonsense mutations , 2007, Nature.

[51]  Jian Wang,et al.  A new synthesis of lysergic acid. , 2004, Organic letters.

[52]  O. Chupakhin,et al.  Nucleophilic substitution or dipolar 1,3-cycloaddition in reactions of cyanamide with 4-arylpyrimidine 1-oxides , 2003 .

[53]  K. Karlin,et al.  Resonance raman investigation of equatorial ligand donor effects on the Cu(2)O(2)(2+) core in end-on and side-on mu-peroxo-dicopper(II) and bis-mu-oxo-dicopper(III) complexes. , 2003, Journal of the American Chemical Society.

[54]  E. Schroeder,et al.  Synthesis of 1-Mono- and 1,3-Di-Substituted 6-Aminouracils. Diuretic Activity , 1951 .